A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population.
Previously-proposed rheumatoid arthritis (RA) HLA-DRB1 susceptibility and protective models were compared, based on amino acids at positions 67-74 and autoantibody combinations. 3 657 RA patients and 1 357 controls were studied using logistic regression, with secondary stratification by anti-citrull...
المؤلفون الرئيسيون: | , , , , , , , , , |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2012
|
_version_ | 1826274277068898304 |
---|---|
author | Mackie, S Taylor, J Martin, S Wordsworth, P Steer, S Wilson, A Worthington, J Emery, P Barrett, J Morgan, A |
author_facet | Mackie, S Taylor, J Martin, S Wordsworth, P Steer, S Wilson, A Worthington, J Emery, P Barrett, J Morgan, A |
author_sort | Mackie, S |
collection | OXFORD |
description | Previously-proposed rheumatoid arthritis (RA) HLA-DRB1 susceptibility and protective models were compared, based on amino acids at positions 67-74 and autoantibody combinations. 3 657 RA patients and 1 357 controls were studied using logistic regression, with secondary stratification by anti-citrullinated peptide antibodies(ACPA) and rheumatoid factor(RF). Susceptibility models were based on previously defined HLA-DRB1 shared epitope(SE) subgroups. (70)DERAA(74), D(70) and I(67) protective models were compared, adjusting for HLA-DRB1 SE. A hierarchy of risk was observed within the HLA-DRB1 SE, particularly for ACPA-positive and RF-positive RA: HLA-DRB1(*)0401∼(*)0404>(*)0101∼(*)1001 ((*)0404>(*)0101: P=0.0003). HLA-DRB1(*)0401/(*)0404 compound heterozygosity conferred a risk similar to (*)0401 homozygosity (P=0.70). Protective effects of D(70) and I(67) were similar. Predictions of the D(70) model fitted the data better than those of the I(67) model. The protective effect of D(70) showed a gene-dose effect (OR 0.82, 95% CI 0.73-0.92, P=5.8 × 10(-4)), but was only seen in RA patients positive for RF or ACPA. HLA-DRB1 SE alleles were also associated with ACPA-negative, RF-positive RA (OR 1.42 (1.15-1.76), P=0.0012). In conclusion, HLA-DRB1 SE alleles show heterogeneity in RA susceptibility; their major effect appears to be mediated by ACPA positivity, but a significant association of HLA-DRB1 SE with RF-positive, ACPA-negative RA was also observed. D(70) specifically protected against antibody-positive RA. |
first_indexed | 2024-03-06T22:41:00Z |
format | Journal article |
id | oxford-uuid:5b8d0d8c-a1e3-46c3-ad1a-61debd0ba82b |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-06T22:41:00Z |
publishDate | 2012 |
record_format | dspace |
spelling | oxford-uuid:5b8d0d8c-a1e3-46c3-ad1a-61debd0ba82b2022-03-26T17:22:48ZA spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:5b8d0d8c-a1e3-46c3-ad1a-61debd0ba82bEnglishSymplectic Elements at Oxford2012Mackie, STaylor, JMartin, SWordsworth, PSteer, SWilson, AWorthington, JEmery, PBarrett, JMorgan, APreviously-proposed rheumatoid arthritis (RA) HLA-DRB1 susceptibility and protective models were compared, based on amino acids at positions 67-74 and autoantibody combinations. 3 657 RA patients and 1 357 controls were studied using logistic regression, with secondary stratification by anti-citrullinated peptide antibodies(ACPA) and rheumatoid factor(RF). Susceptibility models were based on previously defined HLA-DRB1 shared epitope(SE) subgroups. (70)DERAA(74), D(70) and I(67) protective models were compared, adjusting for HLA-DRB1 SE. A hierarchy of risk was observed within the HLA-DRB1 SE, particularly for ACPA-positive and RF-positive RA: HLA-DRB1(*)0401∼(*)0404>(*)0101∼(*)1001 ((*)0404>(*)0101: P=0.0003). HLA-DRB1(*)0401/(*)0404 compound heterozygosity conferred a risk similar to (*)0401 homozygosity (P=0.70). Protective effects of D(70) and I(67) were similar. Predictions of the D(70) model fitted the data better than those of the I(67) model. The protective effect of D(70) showed a gene-dose effect (OR 0.82, 95% CI 0.73-0.92, P=5.8 × 10(-4)), but was only seen in RA patients positive for RF or ACPA. HLA-DRB1 SE alleles were also associated with ACPA-negative, RF-positive RA (OR 1.42 (1.15-1.76), P=0.0012). In conclusion, HLA-DRB1 SE alleles show heterogeneity in RA susceptibility; their major effect appears to be mediated by ACPA positivity, but a significant association of HLA-DRB1 SE with RF-positive, ACPA-negative RA was also observed. D(70) specifically protected against antibody-positive RA. |
spellingShingle | Mackie, S Taylor, J Martin, S Wordsworth, P Steer, S Wilson, A Worthington, J Emery, P Barrett, J Morgan, A A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population. |
title | A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population. |
title_full | A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population. |
title_fullStr | A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population. |
title_full_unstemmed | A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population. |
title_short | A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population. |
title_sort | spectrum of susceptibility to rheumatoid arthritis within hla drb1 stratification by autoantibody status in a large uk population |
work_keys_str_mv | AT mackies aspectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation AT taylorj aspectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation AT martins aspectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation AT wordsworthp aspectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation AT steers aspectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation AT wilsona aspectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation AT worthingtonj aspectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation AT emeryp aspectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation AT barrettj aspectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation AT morgana aspectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation AT mackies spectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation AT taylorj spectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation AT martins spectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation AT wordsworthp spectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation AT steers spectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation AT wilsona spectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation AT worthingtonj spectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation AT emeryp spectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation AT barrettj spectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation AT morgana spectrumofsusceptibilitytorheumatoidarthritiswithinhladrb1stratificationbyautoantibodystatusinalargeukpopulation |